ArticleFrontiers in pharmacology2020

Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes.

Ru-Jun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.